The role of macrophage podosomes in Ebola virus pathogenesis

Information

  • Research Project
  • 10129147
  • ApplicationId
    10129147
  • Core Project Number
    R21AI151717
  • Full Project Number
    1R21AI151717-01A1
  • Serial Number
    151717
  • FOA Number
    PA-19-053
  • Sub Project Id
  • Project Start Date
    11/12/2020 - 3 years ago
  • Project End Date
    10/31/2022 - a year ago
  • Program Officer Name
    DUPUY, LESLEY CONRAD
  • Budget Start Date
    11/12/2020 - 3 years ago
  • Budget End Date
    10/31/2021 - 2 years ago
  • Fiscal Year
    2021
  • Support Year
    01
  • Suffix
    A1
  • Award Notice Date
    11/12/2020 - 3 years ago

The role of macrophage podosomes in Ebola virus pathogenesis

PROJECT SUMMARY Ebola virus (EBOV) is an emerging, highly pathogenic virus associated with increasingly more frequent outbreaks of hemorrhagic disease in human populations. Approved countermeasures to prevent or treat EBOV disease are currently limited. Macrophages are the initial cells targeted by EBOV, and yet, little is known about the exact nature of EBOV-macrophage surface interactions and subsequent uptake into the cell. Due to their migratory properties, macrophages are also believed to rapidly disseminate the virus to distant tissues and organs despite the lack of experimental evidence. We have preliminary data showing that EBOV depends on podosomes, mechanosensitive adhesive structures used by macrophages to migrate through tissues and sample antigens, to enter macrophages. The data also shows that EBOV replication increases macrophage locomotion through a fibrillar 3D matrix and reduces podosome number, suggesting that the virus actively transforms infiltration of tissues by these cells. This proposal aims to examine the interactions between EBOV and podosomes. In Aim 1, we will determine whether podosomes serve as ports for EBOV entry into human macrophages. In Aim 2, we will characterize migratory and invasive properties of macrophages challenged with EBOV. In Aim 3, we will assess host resistance to systemic infection with EBOV in a mouse model of EBOV disease devoid of functional macrophages. Our findings will establish a new model of interactions between EBOV and macrophages, laying the groundwork for further investigations into pathogenesis of filoviruses. Importantly, these discoveries may lead to new areas of development of novel countermeasures targeting EBOV and related viruses.

IC Name
NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES
  • Activity
    R21
  • Administering IC
    AI
  • Application Type
    1
  • Direct Cost Amount
    150000
  • Indirect Cost Amount
    147000
  • Total Cost
    297000
  • Sub Project Total Cost
  • ARRA Funded
    False
  • CFDA Code
    855
  • Ed Inst. Type
  • Funding ICs
    NIAID:297000\
  • Funding Mechanism
    Non-SBIR/STTR RPGs
  • Study Section
    VIRB
  • Study Section Name
    Virology - B Study Section
  • Organization Name
    TEXAS BIOMEDICAL RESEARCH INSTITUTE
  • Organization Department
  • Organization DUNS
    007936834
  • Organization City
    SAN ANTONIO
  • Organization State
    TX
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    782275302
  • Organization District
    UNITED STATES